Metabolic effects of bariatric surgery

European Journal of Endocrinology

Volumn 174, Issue 1, 2016, Pages R19-R28

  Corcelles, Ricard ^a,b   Daigle, Christopher R ^a   Schauer, Philip R ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

^b HOSPITAL CLÍNIC   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

EXENDIN 4; FARNESOID X RECEPTOR; FIBROBLAST GROWTH FACTOR 19; GHRELIN; GLUCAGON LIKE PEPTIDE 1; GLUCAGON LIKE PEPTIDE 2; HEMOGLOBIN A1C; PEPTIDE YY; GLUCOSE BLOOD LEVEL;

AGE DISTRIBUTION; ANEMIA; BARIATRIC SURGERY; BILIOPANCREATIC BYPASS; BODY MASS; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; COMORBIDITY; GASTRIC BANDING; GASTROJEJUNOSTOMY; GLUCOSE HOMEOSTASIS; GLYCEMIC CONTROL; HEART INFARCTION; HUMAN; HYPERGLYCEMIA; HYPERLIPIDEMIA; HYPERTENSION; LUNG EMBOLISM; METABOLISM; MORBIDITY; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; PERIOPERATIVE PERIOD; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN SECRETION; REVIEW; RISK BENEFIT ANALYSIS; STOMACH BYPASS; SURGICAL MORTALITY; TREATMENT OUTCOME; WEIGHT LOSS PROGRAM; WEIGHT REDUCTION; ADULT; ADVERSE EFFECTS; ANALYSIS; CARDIOVASCULAR DISEASE; COMPLICATION; GLUCOSE BLOOD LEVEL; METABOLIC SYNDROME X; MORTALITY; POSTOPERATIVE COMPLICATION; RISK FACTOR;

ADULT; BARIATRIC SURGERY; BLOOD GLUCOSE; CARDIOVASCULAR DISEASES; DIABETES MELLITUS, TYPE 2; HUMANS; HYPERGLYCEMIA; HYPERLIPIDEMIAS; HYPERTENSION; METABOLIC SYNDROME X; OBESITY; POSTOPERATIVE COMPLICATIONS; RISK FACTORS; WEIGHT LOSS;

EID: 84956762192     PISSN: 08044643     EISSN: 1479683X     Source Type: Journal    
DOI: 10.1530/EJE-15-0533     Document Type: Review

References (85)

1. World Health Organisation: Obesity and overweight. Fact sheet N8311. Fact sheet N. 8-11, 2013. http://scholar.google.com/scholar?hl=en& btnG=Search&q=intitle:Media+centre+Obesity+and+overweight#5.
2. Allender S & RaynerM. The burden of overweight and obesity-related ill health in the UK. Obesity Reviews 2007 8 467-473. (doi:10.1111/j.1467-789X.2007.00394.x)
3. Ford ES, Giles WH & Dietz WH. Prevalence of the metabolic syndrome among US adults: Findings from the third National Health and Nutrition Examination Survey. Journal of the American Medical Association 2002 287 356-359. (doi:10.1001/jama.287.3.356)
4. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 2002 106 3143-3421.
5. Wang Y, Beydoun MA, Liang L, Caballero B & Kumanyika SK. Will all Americans become overweight or obese? estimating the progression and cost of the US obesity epidemic Obesity 2008 16 2323-2330. (doi:10.1038/oby.2008.351)
6. Sjöström CD, Lissner L, Wedel H & Sjöström L. Reduction in incidence of diabetes, hypertension and lipid disturbances after intentional weight loss induced by bariatric surgery: The SOS Intervention Study. Obesity Research 1999 7 477-484.
7. Adams TD, Davidson LE, Litwin SE, Kolotkin RL, LaMonte MJ, Pendleton RC, Strong MB, Vinik R, Wanner NA, Hopkins PN et al. Health benefits of gastric bypass surgery after 6 years. Journal of the American Medical Association 2012 308 1122-1131. (doi:10.1001/2012. jama.11164)
8. Flum DR, Belle SH, King WC, Wahed AS, Berk P, Chapman W, Pories W, Courcoulas A, McCloskey C, Mitchell J et al. Perioperative safety in the longitudinal assessment of bariatric surgery. New England Journal of Medicine 2009 361 445-454. (doi:10.1056/ NEJMoa0901836)
9. Christou NV, Sampalis JS, Liberman M, Look D, Auger S, McLean AP & MacLean LD. Surgery decreases long-Term mortality, morbidity, and health care use in morbidly obese patients. Annals of Surgery 2004 240 416-423. (doi:10.1097/01.sla.0000137343.63376.19)
10. Flum DR & Dellinger EP. Impact of gastric bypass operation on survival: A population-based analysis. Journal of the American College of Surgeons 2004 199 543-551. (doi:10.1016/j.jamcollsurg. 2004.06.014)
11. Karlsson J, Taft C, Rydén A, Sjöström L & Sullivan M. Ten-year trends in health-related quality of life after surgical and conventional treatment for severe obesity: The SOS intervention study. International Journal of Obesity 2007 31 1248-1261. (doi:10.1038/sj.ijo. 0803573)
12. Dixon JB, Le Roux CW, Rubino F & Zimmet P. Bariatric surgery for type 2 diabetes. Lancet 2012 379 2300-2311. (doi:10.1016/S0140-6736 (12)60401-2)
13. Angrisani L, Santonicola A, Iovino P, Formisano G, Buchwald H & Scopinaro N. Bariatric Surgery Worldwide 2013. Obesity Surgery 2015 25 1822-1832. (doi:10.1007/s11695-015-1657-z)
14. Sjöström L, Peltonen M, Jacobson P, Sjöström CD, Karason K, Wedel H, Ahlin S, Anveden Å , Bengtsson C, Bergmark G et al. Bariatric surgery and long-Term cardiovascular events. Journal of the American Medical Association 2012 307 56-65. (doi:10.1001/jama.2011.1914)
15. Pories WJ, Swanson MS, MacDonald KG, Long SB, Morris PG, Brown BM, Barakat HA, deRamon RA, Israel G & Dolezal JM. Who would have thought it? An operation proves to be the most effective therapy for adult-onset diabetes mellitus Annals of Surgery 1995 222 339-350. (doi:10.1097/00000658-199509000-00011)
16. Buchwald H, Avidor Y, Braunwald E, Jensen MD, Pories W, Fahrbach K & Schoelles K. Bariatric surgery: A systematic review and meta-Analysis. Journal of the American Medical Association 2004 292 1724-1737. (doi:10.1001/jama.292.14.1724)
17. O'Brien P, McPhail T, Chaston T & Dixon J. Systematic review of medium-Term weight loss after bariatric operations. Obesity Surgery 2006 16 1032-1040. (doi:10.1381/096089206778026316)
18. Nelson DW, Blair KS & MartinMJ. Analysis of obesity-related outcomes and bariatric failure rates with the duodenal switch vs gastric bypass for morbid obesity. Archives of Surgery 2012 147 847-854. (doi:10.1001/ archsurg.2012.1654)
19. O'Brien PE, MacDonald L, Anderson M, Brennan L & Brown WA. Long-Term outcomes after bariatric surgery: Fifteen-year follow-up of adjustable gastric banding and a systematic review of the bariatric surgical literature. Annals of Surgery 2013 257 87-94. (doi:10.1097/SLA. 0b013e31827b6c02)
20. Chakravarty PD, McLaughlin E, Whittaker D, Byrne E, Cowan E, Xu K, Bruce DM & Ford JA. Comparison of laparoscopic adjustable gastric banding (LAGB) with other bariatric procedures; a systematic review of the randomised controlled trials. Surgeon 2012 10 172-182. (doi:10.1016/j.surge.2012.02.001)
21. Kehagias I, Karamanakos SN, Argentou M & Kalfarentzos F. Randomized clinical trial of laparoscopic Roux-en-Y gastric bypass versus laparoscopic sleeve gastrectomy for the management of patients with BMI!50 kg/m2. Obesity Surgery 2011 21 1650-1656. (doi:10.1007/ s11695-011-0479-x)
22. Rawlins L, Rawlins MP, Brown CC & Schumacher DL. Sleeve gastrectomy: 5-year outcomes of a single institution. Surgery for Obesity and Related Diseases 2012 9 21-25. (doi:10.1016/j.soard.2012.08.014)
23. Baptista V & Wassef W. Bariatric procedures: An update on techniques, outcomes and complications. Current Opinion in Gastroenterology 2013 29 684-693. (doi:10.1097/MOG.0b013e3283651af2)
24. Buchwald H, Estok R, Fahrbach K, Banel D & Sledge I. Trends in mortality in bariatric surgery: A systematic review and meta-Analysis. Surgery 2007 142 621-632. (doi:10.1016/j.surg.2007.07.018)
25. Morino M, Toppino M, Forestieri P, Angrisani L, Allaix ME & Scopinaro N. Mortality after bariatric surgery: Analysis of 13,871 morbidly obese patients from a national registry. Annals of Surgery 2007 246 1002-1007. (doi:10.1097/SLA.0b013e31815c404e)
26. Alhamdani A, Wilson M, Jones T, Taqvi L, Gonsalves P, Boyle M, Mahawar K, Balupuri S & Small PK. Laparoscopic adjustable gastric banding: A 10-year single-centre experience of 575 cases with weight loss following surgery. Obesity Surgery 2012 22 1029-1038. (doi:10.1007/s11695-012-0645-9)
27. Thornton CM, Rozen WM, So D, Kaplan ED & Wilkinson S. Reducing band slippage in laparoscopic adjustable gastric banding: The mesh plication pars flaccida technique. Obesity Surgery 2009 19 1702-1706. (doi:10.1007/s11695-008-9672-y)
28. Himpens J, Cadière G-B, Bazi M, Vouche M, Cadière B & Dapri G. Long-Term outcomes of laparoscopic adjustable gastric banding. Archives of Surgery 2011 146 802-807. (doi:10.1001/archsurg.2011.45)
29. Bauman RW & Pirrello JR. Internal hernia at Petersen's space after laparoscopic Roux-en-Y gastric bypass: 6.2% incidence without closure -A single surgeon series of 1047 cases. Surgery for Obesity and Related Diseases 2008 5 565-570. (doi:10.1016/j.soard.2008.10.013)
30. Gandhi AD, Patel RA & Brolin RE. Elective laparoscopy for herald symptoms of mesenteric/internal hernia after laparoscopic Roux-en-Y gastric bypass. Surgery for Obesity and Related Diseases 2008 5 144-149. (doi:10.1016/j.soard.2008.11.002)
31. Yimcharoen P, Heneghan H, Chand B, Talarico JA, Tariq N, Kroh M & Brethauer SA. Successful management of gastrojejunal strictures after gastric bypass: Is timing important? Surgery for Obesity and Related Diseases 2011 8 151-157. (doi:10.1016/j.soard.2011.01.043)
32. Bolen SD, Chang H-Y, Weiner JP, Richards TM, Shore AD, Goodwin SM, Johns RA, Magnuson TH & Clark JM. Clinical outcomes after bariatric surgery: A five-year matched cohort analysis in seven US states. Obesity Surgery 2012 22 749-763. (doi:10.1007/s11695-012-0595-2)
33. El-Hayek K, Timratana P, Shimizu H & Chand B. Marginal ulcer after Roux-en-Y gastric bypass: What have we really learned? Surgical Endoscopy 2012 26 2789-2796. (doi:10.1007/s00464-012-2280-x)
34. Love AL & Billett HH. Obesity, bariatric surgery, and iron deficiency: True, true, true and related. American Journal of Hematology 2008 83 403-409. (doi:10.1002/ajh.21106)
35. Shankar P, Boylan M & Sriram K. Micronutrient deficiencies after bariatric surgery. Nutrition 2009 26 1031-1037. (doi:10.1016/j.nut. 2009.12.003)
36. Inabnet WB, Winegar DA, Sherif B & Sarr MG. Early outcomes of bariatric surgery in patients with metabolic syndrome: An analysis of the bariatric outcomes longitudinal database. Journal of the American College of Surgeons 2012 214 550-556. (doi:10.1016/j.jamcollsurg.2011. 12.019)
37. Rao RS & Kini S. Diabetic and bariatric surgery: A review of the recent trends. Surgical Endoscopy 2012 26 893-903. (doi:10.1007/s00464-011-1976-7)
38. Buchwald H, Estok R, Fahrbach K, Banel D, Jensen MD, Pories WJ, Bantle JP & Sledge I. Weight and type 2 diabetes after bariatric surgery: Systematic review and meta-Analysis. American Journal of Medicine 2009 122 248-256e5. (doi:10.1016/j.amjmed.2008.09.041)
39. Hayes MT, Hunt LA, Foo J, Tychinskaya Y & Stubbs RS. A model for predicting the resolution of type 2 diabetes in severely obese subjects following Roux-en Y gastric bypass surgery. Obesity Surgery 2011 21 910-916. (doi:10.1007/s11695-011-0370-9)
40. Lebovitz HE. Metabolic surgery for type 2 diabetes: Appraisal of clinical evidence and review of randomized controlled clinical trials comparing surgery with medical therapy. Current Atherosclerosis Reports 2013 15 376. (doi:10.1007/s11883-013-0376-y)
41. Brethauer SA, Aminian A, Romero-Talamás H, Batayyah E,Mackey J, Kennedy L, Kashyap SR, Kirwan JP, Rogula T,KrohMet al. Candiabetes be surgically cured? Long-Termmetabolic effects of bariatric surgery in obese patients with type 2 diabetesmellitus Annals of Surgery 2013 258 628-636.
42. Dixon JB, O'Brien PE, Playfair J, Chapman L, Schachter LM, Skinner S, Proietto J, Bailey M & Anderson M. Adjustable gastric banding and conventional therapy for type 2 diabetes: A randomized controlled trial. Journal of the American Medical Association 2008 299 316-323. (doi:10.1001/jama.299.3.316)
43. Ikramuddin S, Korner J, Lee W-J, Connett JE, Inabnet WB, Billington CJ, Thomas AJ, Leslie DB, Chong K, Jeffery RW et al. Roux-en-Y gastric bypass vs intensive medical management for the control of type 2 diabetes, hypertension, and hyperlipidemia: The Diabetes Surgery Study randomized clinical trial. Journal of the American Medical Association 2013 309 2240-2249. (doi:10.1001/jama.2013.5835)
44. Mingrone G, Panunzi S, De Gaetano A, Guidone C, Iaconelli A, Leccesi L, Nanni G, Pomp A, Castagneto M, Ghirlanda G et al. Bariatric surgery versus conventional medical therapy for type 2 diabetes. New England Journal of Medicine 2012 366 1577-1585. (doi:10.1056/ NEJMoa1200111)
45. Schauer PR, Kashyap SR, Wolski K, Brethauer SA, Kirwan JP, Pothier CE, Thomas S, Abood B, Nissen SE & Bhatt DL. Bariatric surgery versus intensive medical therapy in obese patients with diabetes. New England Journal of Medicine 2012 366 1567-1576. (doi:10.1056/NEJMoa 1200225)
46. Schauer PR, Bhatt DL, Kirwan JP, Wolski K, Brethauer SA, Navaneethan SD, Aminian A, Pothier CE, Kim ES, Nissen SE et al. Bariatric surgery versus intensive medical therapy for diabetes -3-year outcomes. New England Journal of Medicine 2014 370 2002-2013. (doi:10.1056/NEJMoa1401329)
47. Liang Z, Wu Q, Chen B, Yu P, Zhao H & Ouyang X. Effect of laparoscopic Roux-en-Y gastric bypass surgery on type 2 diabetes mellitus with hypertension: A randomized controlled trial. Diabetes Research and Clinical Practice 2013 101 50-56. (doi:10.1016/j.diabres. 2013.04.005)
48. Schauer PR, Burguera B, Ikramuddin S, Cottam D, Gourash W, Hamad G, Eid GM, Mattar S, Ramanathan R, Barinas-Mitchel E et al. Effect of laparoscopic Roux-en Y gastric bypass on type 2 diabetes mellitus. Annals of Surgery 2003 238 467-484. (doi:10.1097/01.sla. 0000089851.41115.1b)
49. Halperin F & Goldfine AB. Metabolic surgery for type 2 diabetes: Efficacy and risks. Current Opinion in Endocrinology, Diabetes, and Obesity 2013 20 98-105. (doi:10.1097/MED.0b013e32835edbb0)
50. Rubino F, Forgione A, Cummings DE, Vix M, Gnuli D, Mingrone G, Castagneto M & Marescaux J. The mechanism of diabetes control after gastrointestinal bypass surgery reveals a role of the proximal small intestine in the pathophysiology of type 2 diabetes. Annals of Surgery 2006 244 741-749. (doi:10.1097/01.sla.0000224726. 61448.1b)
51. Schouten R, Rijs CS, Bouvy ND, Hameeteman W, Koek GH, Janssen IM & Greve JW. A multicenter, randomized efficacy study of the EndoBarrier Gastrointestinal Liner for presurgical weight loss prior to bariatric surgery. Annals of Surgery 2010 251 236-243. (doi:10.1097/ SLA.0b013e3181bdfbff)
52. Strader AD, Vahl TP, Jandacek RJ, Woods SC, D'Alessio DA & Seeley RJ. Weight loss through ileal transposition is accompanied by increased ileal hormone secretion and synthesis in rats. American Journal of Physiology. Endocrinology and Metabolism 2005 288 E447-E453. (doi:10.1152/ajpendo.00153.2004)
53. Holst JJ. The physiology of glucagon-like peptide 1. Physiological Reviews 2007 87 1409-1439. (doi:10.1152/physrev.00034.2006)
54. Jørgensen NB, Jacobsen SH, Dirksen C, Bojsen-Møller KN, Naver L, Hvolris L, Clausen TR, Wulff BS, Worm D, Lindqvist Hansen D et al. Acute and long-Term effects of Roux-en-Y gastric bypass on glucose metabolism in subjects with type 2 diabetes and normal glucose tolerance. American Journal of Physiology. Endocrinology and Metabolism 2012 303 E122-E131. (doi:10.1152/ajpendo.00073.2012)
55. Jørgensen NB, Dirksen C, Bojsen-Møller KN, Jacobsen SH, Worm D, Hansen DL, Kristiansen VB, Naver L, Madsbad S & Holst JJ. Exaggerated glucagon-like peptide 1 response is important for improved b-cell function and glucose tolerance after Roux-en-Y gastric bypass in patients with type 2 diabetes. Diabetes 2013 62 3044-3052. (doi:10.2337/db13-0022)
56. Chambers AP, Smith EP, Begg DP, Grayson BE, Sisley S, Greer T, Sorrell J, Lemmen L, LaSance K, Woods SC et al. Regulation of gastric emptying rate and its role in nutrient-induced GLP-1 secretion in rats after vertical sleeve gastrectomy. American Journal of Physiology. Endocrinology and Metabolism 2014 306 E424-E432. (doi:10.1152/ ajpendo.00469.2013)
57. Jiménez A, Casamitjana R, Viaplana-Masclans J, Lacy A & Vidal J. GLP-1 action and glucose tolerance in subjects with remission of type 2 diabetes after gastric bypass surgery. Diabetes Care 2013 36 2062-2069. (doi:10.2337/dc12-1535)
58. Jiménez A, Mari A, Casamitjana R, Lacy A, Ferrannini E & Vidal J. GLP-1 and glucose tolerance after sleeve gastrectomy in morbidly obese subjects with type 2 diabetes. Diabetes 2014 63 3372-3377. (doi:10.2337/db14-0357)
59. Laferrère B, Heshka S, Wang K, Khan Y, McGinty J, Teixeira J, Hart AB & Olivan B. Incretin levels and effect are markedly enhanced 1 month after Roux-en-Y gastric bypass surgery in obese patients with type 2 diabetes. Diabetes Care 2007 30 1709-1716. (doi:10.2337/dc06-1549)
60. Vidal J & Jiménez A. Diabetes remission following metabolic surgery: Is GLP-1 the culprit? Current Atherosclerosis Reports 2013 15 357. (doi:10.1007/s11883-013-0357-1)
61. Shah M, Law JH, Micheletto F, Sathananthan M, Dalla Man C, Cobelli C, Rizza RA, Camilleri M, Zinsmeister AR & Vella A. Contribution of endogenous glucagon-like peptide 1 to glucose metabolism after Roux-en-Y gastric bypass. Diabetes 2014 63 483-493. (doi:10.2337/db13-0954)
62. Seeley RJ, Chambers AP & Sandoval DA. The role of gut adaptation in the potent effects of multiple bariatric surgeries on obesity and diabetes. Cell Metabolism 2015 21 369-378. (doi:10.1016/j.cmet.2015. 01.001)
63. Chambers AP, Stefater MA, Wilson-Perez HE, Jessen L, Sisley S, Ryan KK, Gaitonde S, Sorrell JE, Toure M, Berger J et al. Similar effects of Roux-en-Y gastric bypass and vertical sleeve gastrectomy on glucose regulation in rats. Physiology & Behavior 2011 105 120-123. (doi:10.1016/j.physbeh.2011.05.026)
64. Jiménez A, Casamitjana R, Flores L, Viaplana J, Corcelles R, Lacy A & Vidal J. Long-Term effects of sleeve gastrectomy and Roux-en-Y gastric bypass surgery on type 2 diabetes mellitus in morbidly obese subjects. Annals of Surgery 2012 256 1023-1029. (doi:10.1097/SLA. 0b013e318262ee6b)
65. Pournaras DJ, Glicksman C, Vincent RP, Kuganolipava S, Alaghband-Zadeh J, Mahon D, Bekker JH, Ghatei MA, Bloom SR, Walters JR et al. The role of bile after Roux-en-Y gastric bypass in promoting weight loss and improving glycaemic control. Endocrinology 2012 153 3613-3619. (doi:10.1210/en.2011-2145)
66. Thomas C, Gioiello A, Noriega L, Strehle A, Oury J, Rizzo G, Macchiarulo A, Yamamoto H, Mataki C, Pruzanski M et al. TGR5-mediated bile acid sensing controls glucose homeostasis. Cell Metabolism 2009 10 167-177. (doi:10.1016/j.cmet.2009.08.001)
67. Prawitt J, Abdelkarim M, Stroeve JH, Popescu I, Duez H, Velagapudi VR, Dumont J, Bouchaert E, van Dijk TH, Lucas A et al. Farnesoid X receptor deficiency improves glucose homeostasis in mouse models of obesity. Diabetes 2011 60 1861-1871. (doi:10.2337/db11-0030)
68. Prawitt J, Caron S & Staels B. Bile acid metabolism and the pathogenesis of type 2 diabetes. Current Diabetes Reports 2011 11 160-166. (doi:10.1007/s11892-011-0187-x)
69. Staels B & Kuipers F. Bile acid sequestrants and the treatment of type 2 diabetes mellitus. Drugs 2007 67 1383-1392. (doi:10.2165/ 00003495-200767100-00001)
70. Kohli R, Setchell KD, KirbyM,Myronovych A, Ryan KK, Ibrahim SH, Berger J,Smith K, ToureM,Woods SC et al. Asurgicalmodel inmale obese rats uncovers protective effects of bile acids post-bariatric surgery. Endocrinology 2013 154 2341-2351. (doi:10.1210/en.2012-2069)
71. Patti M-E, Houten SM, Bianco AC, Bernier R, Larsen PR, Holst JJ, Badman MK, Maratos-Flier E, Mun EC, Pihlajamaki J et al. Serum bile acids are higher in humans with prior gastric bypass: Potential contribution to improved glucose and lipid metabolism. Obesity 2009 17 1671-1677. (doi:10.1038/oby.2009.102)
72. Sayin SI, Wahlström A, Felin J, Jäntti S, Marschall H-U, Bamberg K, Angelin B, Hyötyläinen T, Oresic M & Bäckhed F. Gut microbiota regulates bile acid metabolism by reducing the levels of tauro-bmuricholic acid, a naturally occurring FXR antagonist. Cell Metabolism 2013 17 225-235. (doi:10.1016/j.cmet.2013.01.003)
73. Sommer F & Bäckhed F. The gut microbiota -masters of host development and physiology. Nature Reviews. Microbiology 2013 11 227-238. (doi:10.1038/nrmicro2974)
74. Aron-Wisnewsky J & Clement K. The effects of gastrointestinal surgery on gut microbiota: Potential contribution to improved insulin sensitivity. Current Atherosclerosis Reports 2014 16 454. (doi:10.1007/ s11883-014-0454-9)
75. Liou AP, Paziuk M, Luevano J-M, Machineni S, Turnbaugh PJ & Kaplan LM. Conserved shifts in the gut microbiota due to gastric bypass reduce host weight and adiposity. Science Translational Medicine 2013 5 178. (doi:10.1126/scitranslmed.3005687)
76. Sugerman HJ, Wolfe LG, Sica DA & Clore JN. Diabetes and hypertension in severe obesity and effects of gastric bypass-induced weight loss. Annals of Surgery 2003 237 751-756. (doi:10.1097/01.SLA.0000071560. 76194.11)
77. Adams TD, Gress RE, Smith SC, Halverson RC, Simper SC, Rosamond WD, Lamonte MJ, Stroup AM & Hunt SC. Long-Term mortality after gastric bypass surgery. New England Journal of Medicine 2007 357 753-761. (doi:10.1056/NEJMoa066603)
78. Zlabek JA, Grimm MS, Larson CJ, Mathiason MA, Lambert PJ & Kothari SN. The effect of laparoscopic gastric bypass surgery on dyslipidemia in severely obese patients. Surgery for Obesity and Related Diseases 2005 1 537-542. (doi:10.1016/j.soard. 2005.09.009)
79. Kim S & Richards WO. Long-Term follow-up of the metabolic profiles in obese patients with type 2 diabetes mellitus after Roux-en-Y gastric bypass. Annals of Surgery 2010 251 1049-1055. (doi:10.1097/SLA. 0b013e3181d9769b)
80. Iaconelli A, Panunzi S, De Gaetano A, Manco M, Guidone C, Leccesi L, Gniuli D, Nanni G, Castagneto M, Ghirlanda G et al. Effects of bilio-pancreatic diversion on diabetic complications: A 10-year follow-up. Diabetes Care 2011 34 561-567. (doi:10.2337/ dc10-1761)
81. Heneghan HM, Cetin D, Navaneethan SD, Orzech N, Brethauer SA & Schauer PR. Effects of bariatric surgery on diabetic nephropathy after 5 years of follow-up. Surgery for Obesity and Related Diseases 2012 9 7-14. (doi:10.1016/j.soard.2012.08.016)
82. Ashrafian H, Le Roux CW, Darzi A & Athanasiou T. Effects of bariatric surgery on cardiovascular function. Circulation 2008 118 2091-2102. (doi:10.1161/CIRCULATIONAHA.107.721027)
83. Huffman C, Wagman G, Fudim M, Zolty R & Vittorio T. Reversible cardiomyopathies -A review. Transplantation Proceedings 2010 42 3673-3678. (doi:10.1016/j.transproceed.2010.08.034)
84. Pontiroli AE & Morabito A. Long-Term prevention of mortality in morbid obesity through bariatric surgery. A systematic review and meta-Analysis of trials performed with gastric banding and gastric bypass. Annals of Surgery 2011 253 484-487. (doi:10.1097/SLA. 0b013e31820d98cb)
85. Sjöström L, Narbro K, Sjöström CD, Karason K, Larsson B, Wedel H, Lystig T, Sullivan M, Bouchard C, Carlsson B et al. Effects of bariatric surgery on mortality in Swedish obese subjects. New England Journal of Medicine 2007 357 741-752. (doi:10.1056/NEJMoa066254)